An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects
Clinical trial NCT03240809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03240809
- Sponsor
- Bausch Health Americas, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-24
- Primary completion
- 2028-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.